Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5,12-dihydroazapentacene Sodium Disulfonate
2. Azapentacene
1. Phacolysine
2. Phacolysin
3. 3863-80-7
4. Jing Ming
5. Phacolysine Sodium Salt
6. Sodium 5,12-dihydroazapentacene Disulfonate
7. Azapentacene Sulfonate Sodium
8. 58b6f1x64h
9. Sodium 5,12-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
10. Quinoxalino(2,3-b)phenazine, 5,12-dihydro-, Sulfonate, Sodium Salt (1:2:2)
11. 77883-76-2
12. Phacolin
13. Sodium 5,14-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
14. Unii-58b6f1x64h
15. Azapentacene Polysulfonate
16. Azapentacen [who-dd]
17. Dtxsid90959472
18. Disodium 5,14-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
19. Disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate
20. Akos015951394
21. Akos015961917
22. Ac-1537
23. Azapentacene Disulfonate Disodium
24. Azapentacene Polysulfonate Sodium
25. Ft-0673662
26. Azapentacene Polysulfonate Sodium [who-dd]
27. Q9257738
28. Q27261582
29. Quinoxalino(2,3-b)phenazine-2,9-disulfonic Acid, 5,12-dihydro-, Disodium Salt
| Molecular Weight | 488.4 g/mol |
|---|---|
| Molecular Formula | C18H10N4Na2O6S2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 0 |
| Exact Mass | 487.98371496 g/mol |
| Monoisotopic Mass | 487.98371496 g/mol |
| Topological Polar Surface Area | 181 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 845 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Market Place
ABOUT THIS PAGE
A Quinax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quinax, including repackagers and relabelers. The FDA regulates Quinax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quinax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quinax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quinax supplier is an individual or a company that provides Quinax active pharmaceutical ingredient (API) or Quinax finished formulations upon request. The Quinax suppliers may include Quinax API manufacturers, exporters, distributors and traders.
click here to find a list of Quinax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Quinax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quinax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quinax GMP manufacturer or Quinax GMP API supplier for your needs.
A Quinax CoA (Certificate of Analysis) is a formal document that attests to Quinax's compliance with Quinax specifications and serves as a tool for batch-level quality control.
Quinax CoA mostly includes findings from lab analyses of a specific batch. For each Quinax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quinax may be tested according to a variety of international standards, such as European Pharmacopoeia (Quinax EP), Quinax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quinax USP).
LOOKING FOR A SUPPLIER?
